Literature DB >> 6389303

Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study.

R Morecki, J H Glaser, A B Johnson, Y Kress.   

Abstract

This report describes immunocytochemical and ultrastructural methods which led to the identification of Reovirus type 3 (Reo-3) in the porta hepatis of a patient with extrahepatic biliary atresia. The study indicates that Reo-3 antigenic sites are demonstrable by the avidin-biotinylated complex peroxidase method following formalin fixation and paraffin embedding, but are destroyed by freezing and thawing prior to fixation. Deparaffinization of the block and subsequent rembedding in epon-araldite did not alter immunoperoxidase staining. This procedure offered the advantage of higher light microscopic resolution of semithin (1 micron) sections and assisted in the selection of specific areas for ultrastructural studies. Localization of Reo-3 in extrahepatic biliary atresia was confined to a biliary remnant in which there were acutely inflammed, partially necrotic microscopic ducts. Electron microscopic examination of the immunoreactive sites revealed virus-like particles similar in appearance to Reo-3 particles in infected tissue culture cells. The observations presented here support previously reported serologic data which have shown an association between Reo-3 infection and extrahepatic biliary atresia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389303     DOI: 10.1002/hep.1840040608

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

2.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

3.  Phenotypic characterization of mononuclear infiltrate present in liver of biliary atresia.

Authors:  K Chen; J S Gavaler; D H Van Thiel; T Whiteside
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

Review 4.  Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.

Authors:  Kenichi Harada
Journal:  Pediatr Surg Int       Date:  2017-10-16       Impact factor: 1.827

5.  Detection and identification of mammalian reoviruses in surface water by combined cell culture and reverse transcription-PCR.

Authors:  M L Spinner; G D Di Giovanni
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

Review 6.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

7.  Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.

Authors:  A Okamura; K Harada; M Nio; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

Review 8.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease.

Authors:  Erik S Barton; Bryan E Youree; Daniel H Ebert; J Craig Forrest; Jodi L Connolly; Tibor Valyi-Nagy; Kay Washington; J Denise Wetzel; Terence S Dermody
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Biliary atresia.

Authors:  C K Sinha; Mark Davenport
Journal:  J Indian Assoc Pediatr Surg       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.